Multi-omics Analysis
At LIDE, we believe that functional testing becomes truly powerful when combined with deep multi-omics analysis. Our CAP-certified LIWEN Central Laboratory integrates genomics, transcriptomics, and proteomics to help partners uncover drug mechanisms, identify biomarkers, and design smarter clinical trials.
- Genomics – Whole exome sequencing (WES), targeted NGS, low-input OncoVee™ K-cell sequencing for biopsy samples
- Transcriptomics – Functional Genomic Imaging (FGI) for expression clustering into biologically meaningful signatures
- Proteomics – Multiplex tissue imaging platforms, including Imaging Mass Cytometry (IMC) and multiplex immunohistochemistry (mIHC)
- Clinical-grade quality: CAP-certified, ISO15189-compliant lab with GLP-like operations
- Integration with functional models: MiniPDX®, IO-FIVE™, PDX, and CRC samples directly linked to omics analysis
- Biomarker-driven insights: Stratify patients, validate companion diagnostics, and reveal drug resistance pathways
